Business Wire

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Nasdaq

Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and Groundbreaking IOL Data at American Academy of Ophthalmology Annual Meeting

PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...
Healio

Study shows comparative outcomes of toric, non-toric versions of AcrySof IQ PanOptix IOL

Please provide your email address to receive an email when new articles are posted on . A prospective comparative case series of 50 patients implanted bilaterally ...
Healio

FDA panel recommends premarket approval application for AcrySof IQ ReSTOR multifocal toric IOL

Please provide your email address to receive an email when new articles are posted on . GAITHERSBURG, Md. — In an overwhelming panel vote, the U.S. Food and Drug Administration Ophthalmic Devices ...
Pharmabiz

Novartis' eye care division Alcon introduces AcrySof IQ PanOptix Toric intraocular lens for patients with astigmatism undergoing cataract surgery

Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with ...
Medscape

FDA Clears New Corrective Intraocular Lens From Alcon

The US Food and Drug Administration (FDA) has approved a new intraocular lens (IOL) designed to address presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults. The ...
Nasdaq

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...